GRg3 also inhibited growth and promoted apoptosis of gemcitabine-resistant pancreatic cancer cells through upregulation of the PTEN signaling pathway (Zou et al., 2020). This evidence concerns the gene TLE3 and familial pancreatic carcinoma.